Skip to content

3rd Microbiome Drug Development Summit

Helping large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.

View the agenda here.

Pre-arrange to meet with Cobra’s Sales and Marketing Director, Philip Ridley-Smith (pictured) and Scientific Lead in PDPM, Mikael Dahl, using the simple form below:

Arrange your meeting

Fields marked * are required

Arrange your meeting

This website uses cookies. For more information about these please click here.
By continuing to browse you consent to the use of cookies